Both in Pharmaceuticals
uniQure vs Supernus
Over the past year QURE returned −24.7% and SUPN returned −52.1%; their daily moves had a correlation of 0.12.
QURE −24.7% SUPN −52.1%Growth of $1, one year, split-adjusted
| Metric | QURE | SUPN |
|---|---|---|
| Price | $22.93 | $27.28 |
| Market cap | $1.59B | $1.59B |
| Today | −3.94% | −3.09% |
| 1 month | −0.6% | −36.3% |
| 6 months | +0.5% | −47.0% |
| Year to date | −4.2% | −45.1% |
| 1 year | −33.1% | — |
| Revenue growth (YoY) | +11.0% | +18.0% |
| Gross margin | 94.0% | 88.1% |
| Net margin | −1387.8% | 9.2% |
| P/E (TTM) | — | — |
| Price / sales | 85.2× | 1.8× |
| Net cash | $760.2M | $359.5M |
| Dividend yield | — | 29.80% |
| Volatility (60d) | 109.2% | 86.1% |
| Short % of float | 13.2% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).